📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Endologix

1.1 - Company Overview

Endologix Logo

Endologix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of minimally invasive treatments for aortic disorders, offering the AFX2 Endovascular AAA System for abdominal aortic aneurysms with specific aneurysm morphology; the ALTO Abdominal Stent Graft System for infrarenal abdominal aortic aneurysms requiring specific vascular morphology; and the DETOUR System for percutaneous revascularization of symptomatic femoropopliteal lesions in patients suboptimal for surgical or alternative endovascular treatments.

Products and services

  • ALTO Abdominal Stent Graft System: Endovascular, infrarenal-focused stent graft that treats abdominal aortic aneurysms requiring specific vascular morphology for repair, addressing anatomies suitable for endovascular AAA treatment
  • DETOUR System: Percutaneous revascularization system for patients with symptomatic femoropopliteal lesions, intended for those considered suboptimal candidates for surgical or alternative endovascular treatments
  • AFX2 Endovascular AAA System: Endovascular system treating abdominal aortic aneurysms, suitable for patients with specific aneurysm morphology, facilitating repair in anatomies with the specified morphology

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Endologix

Silvergate Pharmaceuticals Logo

Silvergate Pharmaceuticals

HQ: United States Website
  • Description: Provider of pediatric medications, developing and commercializing innovative oral solutions that improve dosing accuracy, safety, and availability. Products include Xatmep (methotrexate) for pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis; Qbrelis (lisinopril) for hypertension (adults/pediatric 6+), adjunct heart failure, and acute MI in adults; and EPANED (enalapril) for hypertension (adults/pediatric >1 month), symptomatic heart failure, and asymptomatic left ventricular dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Silvergate Pharmaceuticals company profile →
ATS Medical Logo

ATS Medical

HQ: United States Website
  • Description: Provider of cardiovascular surgery medical devices, doing business as Medtronic ATS Medical, Inc.; manufactures, markets, and distributes mechanical heart valves (including the ATS Open Pivot Heart Valve), aortic valve graft prostheses, and other cardiovascular accessories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ATS Medical company profile →
Kardium Logo

Kardium

HQ: Canada Website
  • Description: Provider of the Globe Pulsed Field System for the diagnosis and treatment of atrial fibrillation, integrating pulmonary vein isolation, high-definition mapping, and atrial ablation in a single catheter. Offers the Globe PF Mapping and Ablation System with a 122-electrode catheter, the Globe Catheter (30 mm spherical array, 122 electrodes), and the PULSAR clinical study evaluating safety and effectiveness.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kardium company profile →
NovaCardia Logo

NovaCardia

HQ: United States Website
  • Description: Provider of cardiovascular drug development and commercialization of novel small molecule drugs to improve care for patients with cardiovascular disease; a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NovaCardia company profile →
Amarin Logo

Amarin

HQ: Ireland Website
  • Description: Provider of prescription cardiovascular therapy and clinical research, including VASCEPA/VAZKEPA (icosapent ethyl) to reduce cardiovascular risk in patients with elevated triglycerides and established cardiovascular disease, and the REDUCE-IT global outcomes study evaluating VASCEPA in patients with controlled LDL-C and elevated triglycerides to reduce cardiovascular events.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amarin company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Endologix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Endologix

2.2 - Growth funds investing in similar companies to Endologix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Endologix

4.2 - Public trading comparable groups for Endologix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Endologix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Endologix

What does Endologix do?

Endologix is a provider of minimally invasive treatments for aortic disorders, offering the AFX2 Endovascular AAA System for abdominal aortic aneurysms with specific aneurysm morphology; the ALTO Abdominal Stent Graft System for infrarenal abdominal aortic aneurysms requiring specific vascular morphology; and the DETOUR System for percutaneous revascularization of symptomatic femoropopliteal lesions in patients suboptimal for surgical or alternative endovascular treatments.

Who are Endologix's competitors?

Endologix's competitors and similar companies include Silvergate Pharmaceuticals, ATS Medical, Kardium, NovaCardia, and Amarin.

Where is Endologix headquartered?

Endologix is headquartered in United States.

How many employees does Endologix have?

Endologix has 1,000 employees 🔒.

When was Endologix founded?

Endologix was founded in 2010 🔒.

What sector and industry vertical is Endologix in?

Endologix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Endologix

Who are the top strategic acquirers in Endologix's sector and industry

Top strategic M&A buyers and acquirers in Endologix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Endologix?

Top strategic M&A buyers groups and sectors for Endologix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Endologix's sector and industry vertical

Which are the top PE firms investing in Endologix's sector and industry vertical?

Top PE firms investing in Endologix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Endologix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Endologix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Endologix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Endologix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Endologix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Endologix?

The key public trading comparables and valuation benchmarks for Endologix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Endologix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Endologix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Endologix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Endologix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Endologix's' sector and industry vertical?

Access recent funding rounds and capital raises in Endologix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Endologix

Launch login modal Launch register modal